CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer
CytRx Corporation (NASDAQ: CYTR), a...
Read MoreCytRx Corporation (NASDAQ: CYTR), a...
Read MoreDespite numerous comments raising questions...
Read MoreFrench pharma major Sanofi (Euronext:...
Read MoreWith no Food and Drug...
Read MoreHealth technology firm Royal Philips...
Read MoreAstraZeneca today announced positive results...
Read MorePharma major Lupin Limited (Lupin)...
Read MoreGlenmark Pharmaceuticals Ltd., a research-led...
Read More